Target intelligence / Profile preview

Hydrogen-potassium ATPase alpha subunit (H+/K+ ATPase alpha subunit)

Target
H+/K+ ATPase alpha subunit
Molecular classification
Enzyme, Ion transporter, P-type ATPase family
01

Overview

The hydrogen-potassium ATPase alpha subunit is the catalytic component of the gastric proton pump that exchanges cytoplasmic hydronium ions for extracellular potassium ions via ATP hydrolysis, serving as the final step in gastric acid secretion. It is encoded by the ATP4A gene and structurally consists of approximately 1,000 amino acids, incorporating multiple transmembrane domains. The enzyme functions as an α,β-heterodimer with the β subunit stabilizing and targeting the complex to the membrane. This ATPase is the principal target for proton pump inhibitors (PPIs), which revolutionized the treatment of peptic ulcer disease and acid reflux disorders by blocking acid secretion at its source.

Other names
Gastric H+/K+ ATPaseH,K-ATPase alpha subunitATP4AProton pump alpha subunit
02

Mechanism of action

Inhibition of gastric acid secretion by covalent or competitive binding to the pump, blocking the catalytic cycle and ion transport. Irreversible inhibition (PPIs covalently modify the enzyme). Reversible inhibition (potassium-competitive inhibitors).

03

Biological functions

Gastric acid secretionIon exchange (proton-potassium exchange)Maintenance of stomach lumen acidityActivation of digestive processes (via acid-mediated pepsin activation)
04

Disease associations

Peptic ulcer diseaseGastroesophageal reflux disease (GERD)Zollinger-Ellison syndromeOther acid-related disorders
05

Safety considerations

Long-term reduction of gastric acidity may increase risk of infections (e.g., C. difficile)Hypergastrinemia (elevated gastrin)Possible nutrient malabsorption (e.g., B12, magnesium)Rebound acid hypersecretion after discontinuation
06

Interacting drugs

Proton pump inhibitors (PPIs) such as omeprazole, lansoprazole, pantoprazole, esomeprazole

2 more in the full profile.

07

Biomarkers

Gastric pH (as efficacy biomarker)Plasma gastrin (secondary increase when acid suppression is profound)Not commonly used for patient selection at the molecular level

Beyond the preview

Go deeper on Hydrogen-potassium ATPase alpha subunit (H+/K+ ATPase alpha subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydrogen-potassium ATPase alpha subunit (H+/K+ ATPase alpha subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call